Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

BACKGROUND: Prevalence and outcomes of coronavirus disease (COVID)-19 in relation to immunomodulatory medications are still unknown. The aim of the study is to investigate the impact of glucocorticoids and immunosuppressive agents on COVID-19 in a large cohort of patients with chronic immune-mediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Favalli, Ennio Giulio, Bugatti, Serena, Klersy, Catherine, Biggioggero, Martina, Rossi, Silvia, De Lucia, Orazio, Bobbio-Pallavicini, Francesca, Murgo, Antonella, Balduzzi, Silvia, Caporali, Roberto, Montecucco, Carlomaurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772957/
https://www.ncbi.nlm.nih.gov/pubmed/33380344
http://dx.doi.org/10.1186/s13075-020-02395-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772957/
https://www.ncbi.nlm.nih.gov/pubmed/33380344
http://dx.doi.org/10.1186/s13075-020-02395-6

Ejemplares similares